According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...
Next-day HIV viral load testing results do not significantly improve linkage to treatment or prevention care for adults at risk for acquisition or people with HIV not receiving daily antiretroviral ...
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect ...
Colorized transmission electron micrograph of multiple HIV-1 virus particles (green) budding from a cell projection from an H9 cell (burgundy). Image captured at the NIAID Integrated Research Facility ...
Hosted on MSN
Clinical trial suggests knowing HIV 'viral load' doesn't improve number of patients seeking needed care
According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...
WHO Prequalification approval allows Abbott ( <a href="http://www.Abbott.com" id="59c52bdb-d8e4-395f-aca5-b1ec1e14bb1c"> www.Abbott.com </a> ) to bring critical ...
TUESDAY, Dec. 23, 2025 (HealthDay News) -- For adults at risk for HIV acquisition or people with HIV (PWH) not taking daily antiretroviral therapy (ART), an HIV viral load (VL) test with next-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback